Typically, the recommended dose for oral use is 1-6 g three times a day.
Occupational exposure to fenugreek has been reported to cause asthma, and inhalation of seed powder may cause allergic symptoms such as rhinorrhea and wheezing.
Side Effects and Interactions
The absorption of drugs taken concomitantly with fenugreek may be delayed or impaired because of the herb's high mucilaginous fiber conten. This effect has not been studied. Poultices and other external formulations have been used for wounds and skin irritations. Because the herb appears safe and well tolerated, and may be a good source of fiber, it is not unreasonable for diabetic or hypercholesterolemic patients to try fenugreek supplements, as long as clinical effects are monitored.5 g b.
No significant adverse effects were reported in any of the clinical trials, apart from occasional flatulence and diarrhea.
Purverized seeds have been mixed with water to make a paste and used as a poultice. of encapsulated fenu­greek seed, no effect was seen on cholesterol in healthy subjects, and platelet aggregation, fibrinolytic activity, and fibrinogen levels also were not affected.Fenugreek
Fenugreek Polyester yarns for ribbon bears hard, irregularly shaped seeds, which are used both as a spice and as an herbal medicine. However, this trial was not ran­domized; there was no mention of blinding; and the data were poorly reported-thus casting doubts on the reported beneficial results. The seeds have a characteristic odor and a somewhat bitter taste.
Uses and Benefits:
Fenugreek came from the herbal medicine traditions of the Middle East, India, and Egypt, and later in China and Europe, and was favored as a digestive aid for dyspepsia, intestinal gas, ,anorexia, and diarrhea.
In a placebo-controlled trial of 2. In a patient previously stabilized on warfarin, oral consumption of one fenugreek capsule and 10 drops of a boldo <em>(Peumus boldus) </em>extract, both with meals, was associated with an elevation of the INR (from 2. Doses as high as 50-100 g/day have been used in clinical trials.Ld. Characteristics of blinding were not mentioned in the study.3 to 3. In a recent RCT with 18 type diabetics, 25- and 50-g doses of defatted fenugreek were compared to placebo for 20 days.
Animal studies and inadequately controlled clinical trials suggest that fenugreek lowers serum cholesterol and glucose levels.
Fenugreek seeds contain 45-60% carbohy­drates (mainly mucilaginous fiber), proteins high in lysine and Iryptophan, 5-10% fixed oils, flavonoids, alkaloids such as Irigonelline, saponins such as fenugreekine, and coumarins.4). However, high-quality controlled trials are lacking, and thus efficacy has not been adequately demonstrated. None of the other claimed uses or indications for fenugreek have been evaluated clinically. Fenugreek is native to Asia and southeastern Europe.
Preparations & Doses:
Common oral preparations include pulverized seeds, capsules with seed powder, and teas. However, in a subgroup of 30 patients with type diabetes and coronary artery disease, reductions in total cholesterol (about 6%) and triglycerides (about 16%) were reported by the end of 3 months. There were significant decreases in total cholesterol, triglyc­erides, and VLDL.
The hypoglycemic and lipid-lowering effects of fenugreek seed have been studied in many clinical trials, almost all from India. Because of reported oxytocic and isolated uterine stimulant activity in animals, fenugreek in doses larger than those encountered in foods is not recommended during pregnancy. Rare allergic symptoms, including numbness, swelling, and wheezing, have been reported with fenugreek applied topically. Fenugreek's most common modern indications include diabetes and hyperlipidemia.Both the coumarins and the fenugreek alkaloid, trigonelline, caused hypoglycemia or inhibited experimentally-induced hype­glycemia in different animal models. An interesting side effect is the peculiar odor of maple syrup that fenugreek has been reported to impart to urine when ingested in large amounts.
Similarly, various hypotheses about the mechanism of the hypo­glycemic activity of fenugreek have been postulated, including delayed gastric emptying and an agonist effect on insulin receptors. It was also used to treat chronic cough, bronchitis, fever, sore throat, and mouth ulcers. Although all of these studies reported positive effects, most of the trials were small, and study methodology and reporting of data were generally of poor quality. Most of the trials were uncontrolled, and none of the controlled studies were blinded. The effect was confirmed with rechallenge, but the cause and effect relationship with fenugreek is not known.